Concluding Notes of Special Issue “α-7 Nicotinic Receptor (α7-nAChR): One Target Different Diseases”

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|13|5|726-727

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.5, 2012-05, pp. : 726-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: α7-Nicotinic Receptor (α7-nAChR): One Target Different Diseases (Guest Editors: Patrizia Russo, Alfredo Cesario and Alessio Cardinale)]

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 573-573

Bentham Science Publishers

Access to resources Recommend Favorite

The Recent Development of 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2134-2151

Bentham Science Publishers

Access to resources Recommend Favorite

A New “Era” for the α7-nAChR

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 721-725

Bentham Science Publishers

Access to resources Recommend Favorite

Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 688-694

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches to Study the Involvement of α7-nAChR in Human Diseases

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 579-586

Bentham Science Publishers

Access to resources Recommend Favorite